CIM
GILD icon

CIM Investment Management’s Gilead Sciences GILD Stock Holding History

CIM Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Sell
2,831
-14
-0.5% -$1.96K 0.11% 152
2025
Q4 		$349K Hold
2,845
– – 0.09% 171
2025
Q3 		$316K Sell
2,845
-3,754
-57% -$427K 0.09% 176
2025
Q2 		$663K Buy
6,599
+3,712
+129% +$395K 0.13% 146
2025
Q1 		$323K Sell
2,887
-838
-22% -$86.5K 0.07% 167
2024
Q4 		$344K Sell
3,725
-106
-3% -$9.54K 0.1% 167
2024
Q3 		$321K Sell
3,831
-215
-5% -$16.4K 0.1% 176
2024
Q2 		$278K Sell
4,046
-70
-2% -$4.67K 0.09% 189
2024
Q1 		$301K Hold
4,116
– – 0.09% 207
2023
Q4 		$333K Hold
4,116
– – 0.11% 178
2023
Q3 		$308K Sell
4,116
-70
-2% -$5.38K 0.11% 177
2023
Q2 		$323K Buy
4,186
+7
+0.2% +$558 0.11% 175
2023
Q1 		$347K Buy
+4,179
New +$346K 0.13% 166
2022
Q2 		– Sell
-9,588
Closed -$570K – 244
2022
Q1 		$570K Sell
9,588
-11
-0.1% -$703 0.19% 107
2021
Q4 		$697K Sell
9,599
-179
-2% -$12.3K 0.21% 97
2021
Q3 		$683K Sell
9,778
-10,218
-51% -$718K 0.21% 95
2021
Q2 		$1.38M Sell
19,996
-177
-0.9% -$11.8K 0.43% 34
2021
Q1 		$1.3M Sell
20,173
-754
-4% -$48.6K 0.41% 39
2020
Q4 		$1.22M Buy
20,927
+6,591
+46% +$398K 0.4% 43
2020
Q3 		$906K Buy
14,336
+8,352
+140% +$579K 0.34% 54
2020
Q2 		$460K Sell
5,984
-5,992
-50% -$459K 0.19% 113
2020
Q1 		$895K Buy
11,976
+430
+4% +$29.7K 0.44% 37
2019
Q4 		$750K Hold
11,546
– – 0.3% 73
2019
Q3 		$732K Sell
11,546
-1,287
-10% -$84.1K 0.27% 64
2019
Q2 		$867K Buy
12,833
+523
+4% +$34.4K 0.32% 60
2019
Q1 		$800K Sell
12,310
-1,022
-8% -$67.9K 0.31% 59
2018
Q4 		$834K Sell
13,332
-544
-4% -$38K 0.36% 52
2018
Q3 		$1.07M Sell
13,876
-7
-0.1% -$529 0.38% 37
2018
Q2 		$983K Sell
13,883
-391
-3% -$27.6K 0.34% 60
2018
Q1 		$1.08M Sell
14,274
-352
-2% -$28K 0.37% 47
2017
Q4 		$1.05M Buy
14,626
+8,131
+125% +$617K 0.36% 58
2017
Q3 		$526K Sell
6,495
-6,186
-49% -$473K 0.19% 152
2017
Q2 		$898K Sell
12,681
-196
-2% -$13K 0.32% 67
2017
Q1 		$875K Sell
12,877
-1,174
-8% -$82.6K 0.3% 75
2016
Q4 		$1.01M Buy
14,051
+158
+1% +$11.7K 0.37% 57
2016
Q3 		$1.1M Sell
13,893
-1,060
-7% -$86.1K 0.42% 42
2016
Q2 		$1.25M Sell
14,953
-630
-4% -$55.9K 0.52% 40
2016
Q1 		$1.43M Sell
15,583
-1,935
-11% -$174K 0.62% 30
2015
Q4 		$1.77M Hold
17,518
– – 0.81% 25
2015
Q3 		$1.72M Buy
17,518
+215
+1% +$23.9K 0.83% 22
2015
Q2 		$2.03M Sell
17,303
-88
-0.5% -$9.62K 0.89% 18
2015
Q1 		$1.71M Sell
17,391
-8,694
-33% -$883K 0.74% 24
2014
Q4 		$2.46M Hold
26,085
– – 1.13% 17
2014
Q3 		$2.78M Sell
26,085
-1,176
-4% -$115K 1.41% 14
2014
Q2 		$2.26M Sell
27,261
-721
-3% -$56.1K 1.13% 19
2014
Q1 		$1.98M Buy
27,982
+11,383
+69% +$893K 0.91% 23
2013
Q4 		$1.25M Sell
16,599
-14,299
-46% -$996K 0.64% 54
2013
Q3 		$1.94M Hold
30,898
– – 1.15% 22
2013
Q2 		$1.58M Buy
+30,898
New +$1.61M 0.94% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIM Investment Management's GILD Position: Q1 2026 in Review

CIM Investment Management reduced its Gilead Sciences (GILD) stake by 0.49% in Q1 2026, selling an estimated $1.96K and leaving 2,831 shares worth $395K. The position accounts for 0.11% of the portfolio, ranked #152.

CIM Investment Management first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.78M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • CIM Investment Management held 2,831 shares of Gilead Sciences worth $395K as of Q1 2026.
  • CIM Investment Management sold 14 Gilead Sciences shares in Q1 2026, an estimated $1.96K.
  • Gilead Sciences made up 0.11% of CIM Investment Management's portfolio in Q1 2026, its #152 holding.
  • CIM Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
  • CIM Investment Management's Gilead Sciences position peaked at $2.78M in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.